Walleye Capital’s Aveanna Healthcare AVAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.7M Buy
+198,638
New +$1.4M 0.01% 1657
2025
Q4
Sell
-309,366
Closed -$2.74M 4554
2025
Q3
$2.74M Buy
+309,366
New +$1.96M 0.01% 1352
2025
Q2
Sell
-51,470
Closed -$279K 4492
2025
Q1
$279K Buy
51,470
+37,517
+269% +$177K ﹤0.01% 3012
2024
Q4
$63.8K Buy
+13,953
New +$71.5K ﹤0.01% 4294
2021
Q3
Sell
-200,000
Closed -$2.47M 1587
2021
Q2
$2.47M Buy
+200,000
New +$2.37M 0.08% 201

Other funds holding AVAH

Walleye Capital's AVAH Position: Q2 2026 in Review

Walleye Capital opened a new position in Aveanna Healthcare (AVAH) in Q2 2026: 198,638 shares worth $1.7M. The stake represents 0.01% of the portfolio and ranks #1657 among its holdings. This is a return to the name: Walleye Capital previously reported a position in AVAH as recently as Q3 2025.

Walleye Capital first reported a position in AVAH in Q2 2021 and has held it in 5 quarters since. The position peaked at $2.74M in Q3 2025. 215 funds tracked by Wall St. Rank hold AVAH as of Q2 2026.

  • Walleye Capital held 198,638 shares of Aveanna Healthcare worth $1.7M as of Q2 2026.
  • Aveanna Healthcare was a new Walleye Capital position in Q2 2026.
  • Aveanna Healthcare made up 0.01% of Walleye Capital's portfolio in Q2 2026, its #1657 holding.
  • Walleye Capital first reported a position in Aveanna Healthcare in Q2 2021 and has held it in 5 quarters since.
  • Walleye Capital's Aveanna Healthcare position peaked at $2.74M in Q3 2025.
  • 215 funds tracked by Wall St. Rank held Aveanna Healthcare as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.